Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PAUL LEIS

Allopathic & Osteopathic Physicians Hospitalist

NPI
1871913830
CMS profile
3320148
Location
MANHASSET, NY

General Payments · PY2018–2024

$5,110.32

  • Reported across 159 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$391.31

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $391.31 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $320.97 9
PY2019 $1,280.70 30
PY2020 $1,760.31 51
PY2021 $819.97 34
PY2022 $324.18 10
PY2023 $212.88 9
PY2024 $391.31 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alnylam Pharmaceuticals Inc. $30.02 10/09/2024 Food and Beverage Undisputed 01/23/2026 1125838699 CMS
AstraZeneca Pharmaceuticals LP $14.73 04/25/2024 Food and Beverage Undisputed 01/23/2026 1104708075 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.11 09/05/2024 Food and Beverage Undisputed 01/23/2026 1086109618 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.98 02/28/2024 Food and Beverage Undisputed 01/23/2026 1118206372 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $33.84 03/13/2024 Food and Beverage Undisputed 01/23/2026 1118206380 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.85 04/17/2024 Food and Beverage Undisputed 01/23/2026 1118206368 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $30.58 05/15/2024 Food and Beverage Undisputed 01/23/2026 1118206376 CMS
ENDOTRONIX, INC. $31.19 12/11/2024 Food and Beverage Undisputed 01/23/2026 1145823531 CMS
Kiniksa Pharmaceuticals International, plc $24.42 02/06/2024 Food and Beverage Undisputed 01/23/2026 1154854416 CMS
Kiniksa Pharmaceuticals International, plc $18.10 05/03/2024 Food and Beverage Undisputed 01/23/2026 1154854448 CMS
Kiniksa Pharmaceuticals International, plc $25.39 10/09/2024 Food and Beverage Undisputed 01/23/2026 1154854490 CMS
Kiniksa Pharmaceuticals International, plc $22.30 10/11/2024 Food and Beverage Undisputed 01/23/2026 1154854492 CMS
Merck Sharp & Dohme LLC $26.47 11/20/2024 Food and Beverage Undisputed 01/23/2026 1141630890 CMS
Novartis Pharmaceuticals Corporation $25.51 01/16/2024 Food and Beverage Undisputed 01/23/2026 1086980722 CMS
Novartis Pharmaceuticals Corporation $20.14 05/10/2024 Food and Beverage Undisputed 01/23/2026 1086980724 CMS
Novartis Pharmaceuticals Corporation $21.68 09/17/2024 Food and Beverage Undisputed 01/23/2026 1086980726 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.